Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bofill

Showing results (561-570 of 594) with videos related to

Pageof 60
Sort By:
Surgical Endoscopy|June 15, 2023
Endoscopic ultrasound-guided versus percutaneous drainage for the management of post-operative fluid collections after distal pancreatectomyDelvise T Fogwe, Jad P AbiMansour, Mark J Truty, et al.
The New England Journal of Medicine|January 21, 2026
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast CancerSara M Tolaney, Evandro de Azambuja, Kevin Kalinsky, et al.
Biomedicines|December 23, 2023
Clinical and Microbiological Impact of Implementing a Decision Support Algorithm through Microbiologic Rapid Diagnosis in Critically Ill Patients: An Epidemiological Retrospective Pre-/Post-Intervention StudyAlejandro Rodríguez, Frederic Gómez, Carolina Sarvisé, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 28, 2017
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practiceI Blancas, M Fontanillas, V Conde, et al.
Autoimmunity Reviews|April 1, 2024
Disease phenotypes in adult patients with suspected undifferentiated autoinflammatory diseases and PFAPA syndrome: Clinical and therapeutic implicationsVerónica Gómez-Caverzaschi, Jordi Yagüe, Gerard Espinosa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 5, 2018
Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practiceI Blancas, M Fontanillas, V Conde, et al.
Journal of Drug Assessment|May 10, 2019
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologistsPedro Sánchez-Rovira, Pilar Zamora, Javier Salvador-Bofill, et al.
Bioinformatics (Oxford, England)|September 11, 2019
Unification of miRNA and isomiR research: the mirGFF3 format and the mirtop APIThomas Desvignes, Phillipe Loher, Karen Eilbeck, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 13, 2023
Standardising outcome reporting for clinical trials of interventions for heavy menstrual bleeding: Development of a core outcome setNatalie A M Cooper, Carol Rivas, Malcolm G Munro, et al.
Breast (Edinburgh, Scotland)|August 8, 2024
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 studyJosé Enrique Alés-Martínez, Judith Balmaña, Pedro Sánchez-Rovira, et al.
Pageof 60

Showing results (561-570 of 594) with videos related to

Sort By:
Pageof 60
Surgical Endoscopy|June 15, 2023
Endoscopic ultrasound-guided versus percutaneous drainage for the management of post-operative fluid collections after distal pancreatectomyDelvise T Fogwe, Jad P AbiMansour, Mark J Truty, et al.
The New England Journal of Medicine|January 21, 2026
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast CancerSara M Tolaney, Evandro de Azambuja, Kevin Kalinsky, et al.
Biomedicines|December 23, 2023
Clinical and Microbiological Impact of Implementing a Decision Support Algorithm through Microbiologic Rapid Diagnosis in Critically Ill Patients: An Epidemiological Retrospective Pre-/Post-Intervention StudyAlejandro Rodríguez, Frederic Gómez, Carolina Sarvisé, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 28, 2017
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practiceI Blancas, M Fontanillas, V Conde, et al.
Autoimmunity Reviews|April 1, 2024
Disease phenotypes in adult patients with suspected undifferentiated autoinflammatory diseases and PFAPA syndrome: Clinical and therapeutic implicationsVerónica Gómez-Caverzaschi, Jordi Yagüe, Gerard Espinosa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 5, 2018
Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practiceI Blancas, M Fontanillas, V Conde, et al.
Journal of Drug Assessment|May 10, 2019
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologistsPedro Sánchez-Rovira, Pilar Zamora, Javier Salvador-Bofill, et al.
Bioinformatics (Oxford, England)|September 11, 2019
Unification of miRNA and isomiR research: the mirGFF3 format and the mirtop APIThomas Desvignes, Phillipe Loher, Karen Eilbeck, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 13, 2023
Standardising outcome reporting for clinical trials of interventions for heavy menstrual bleeding: Development of a core outcome setNatalie A M Cooper, Carol Rivas, Malcolm G Munro, et al.
Breast (Edinburgh, Scotland)|August 8, 2024
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 studyJosé Enrique Alés-Martínez, Judith Balmaña, Pedro Sánchez-Rovira, et al.
Pageof 60